Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
21
BSGM Quote, Financials, Valuation and Earnings
Last price:
$4.75
Seasonality move
:
-18.55%
Day range:
$4.72 - $5.37
52-week range:
$0.23 - $14.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
172.76x
P/B ratio:
49.77x
Volume:
1M
Avg. volume:
1.4M
1-year change:
1018.96%
Market cap:
$129.6M
Revenue:
$40K
EPS (TTM):
-$0.59
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BSGM
BioSig Technologies
|
-- | -$0.04 | -100% | -83.33% | $10.00 |
|
ELMD
Electromed
|
$16.4M | -- | 12.26% | -- | $33.50 |
|
IRIX
IRIDEX
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo
|
$9.1M | -$0.11 | 21.62% | -253.33% | $8.70 |
|
NDRA
ENDRA Life Sciences
|
-- | -$2.27 | -- | -97.63% | $46.00 |
|
STXS
Stereotaxis
|
$7.8M | -$0.07 | 72.15% | -3.57% | $4.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BSGM
BioSig Technologies
|
$4.75 | $10.00 | $129.6M | -- | $0.00 | 0% | 172.76x |
|
ELMD
Electromed
|
$18.65 | $33.50 | $156.4M | 23.61x | $0.00 | 0% | 2.72x |
|
IRIX
IRIDEX
|
$1.07 | -- | $18M | -- | $0.00 | 0% | 0.36x |
|
MYO
Myomo
|
$1.95 | $8.70 | $70.2M | -- | $0.00 | 0% | 1.97x |
|
NDRA
ENDRA Life Sciences
|
$7.23 | $46.00 | $5.3M | -- | $0.00 | 0% | 5.64x |
|
STXS
Stereotaxis
|
$2.39 | $4.50 | $205.5M | -- | $0.00 | 0% | 7.49x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BSGM
BioSig Technologies
|
-- | 16.724 | 1.94% | 0.75x |
|
ELMD
Electromed
|
-- | 2.259 | -- | 4.79x |
|
IRIX
IRIDEX
|
81.05% | 1.324 | 21.92% | 1.11x |
|
MYO
Myomo
|
-- | -0.171 | -- | 2.24x |
|
NDRA
ENDRA Life Sciences
|
-- | -4.726 | -- | -- |
|
STXS
Stereotaxis
|
-- | 2.022 | -- | 0.62x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BSGM
BioSig Technologies
|
-- | -$3M | -- | -- | -30046.15% | -$1.1M |
|
ELMD
Electromed
|
$12.2M | $2.1M | 16.57% | 16.57% | 13.65% | $2.2M |
|
IRIX
IRIDEX
|
$5.1M | -$205K | -140.14% | -218.69% | -1.72% | -$1.2M |
|
MYO
Myomo
|
$6.6M | -$3.5M | -38.11% | -38.11% | -35.81% | -$3.3M |
|
NDRA
ENDRA Life Sciences
|
-- | -$1.5M | -- | -- | -- | -$1.3M |
|
STXS
Stereotaxis
|
$4.1M | -$5.9M | -174.6% | -174.6% | -79.35% | -$1.8M |
BioSig Technologies vs. Competitors
-
Which has Higher Returns BSGM or ELMD?
Electromed has a net margin of -30115.39% compared to BioSig Technologies's net margin of 12.06%. BioSig Technologies's return on equity of -- beat Electromed's return on equity of 16.57%.
Company Gross Margin Earnings Per Share Invested Capital BSGMBioSig Technologies-- -$0.14 $116K ELMDElectromed77.97% $0.21 $43.9M -
What do Analysts Say About BSGM or ELMD?
BioSig Technologies has a consensus price target of $10.00, signalling upside risk potential of 110.53%. On the other hand Electromed has an analysts' consensus of $33.50 which suggests that it could grow by 79.63%. Given that BioSig Technologies has higher upside potential than Electromed, analysts believe BioSig Technologies is more attractive than Electromed.
Company Buy Ratings Hold Ratings Sell Ratings BSGMBioSig Technologies1 0 0 ELMDElectromed2 0 0 -
Is BSGM or ELMD More Risky?
BioSig Technologies has a beta of 1.706, which suggesting that the stock is 70.624% more volatile than S&P 500. In comparison Electromed has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.696%.
-
Which is a Better Dividend Stock BSGM or ELMD?
BioSig Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioSig Technologies pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSGM or ELMD?
BioSig Technologies quarterly revenues are $13K, which are smaller than Electromed quarterly revenues of $15.7M. BioSig Technologies's net income of -$2.8M is lower than Electromed's net income of $1.9M. Notably, BioSig Technologies's price-to-earnings ratio is -- while Electromed's PE ratio is 23.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioSig Technologies is 172.76x versus 2.72x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSGMBioSig Technologies172.76x -- $13K -$2.8M ELMDElectromed2.72x 23.61x $15.7M $1.9M
-
Which has Higher Returns BSGM or IRIX?
IRIDEX has a net margin of -30115.39% compared to BioSig Technologies's net margin of -14.17%. BioSig Technologies's return on equity of -- beat IRIDEX's return on equity of -218.69%.
Company Gross Margin Earnings Per Share Invested Capital BSGMBioSig Technologies-- -$0.14 $116K IRIXIRIDEX42.49% -$0.10 $4.5M -
What do Analysts Say About BSGM or IRIX?
BioSig Technologies has a consensus price target of $10.00, signalling upside risk potential of 110.53%. On the other hand IRIDEX has an analysts' consensus of -- which suggests that it could grow by 86.92%. Given that BioSig Technologies has higher upside potential than IRIDEX, analysts believe BioSig Technologies is more attractive than IRIDEX.
Company Buy Ratings Hold Ratings Sell Ratings BSGMBioSig Technologies1 0 0 IRIXIRIDEX0 0 0 -
Is BSGM or IRIX More Risky?
BioSig Technologies has a beta of 1.706, which suggesting that the stock is 70.624% more volatile than S&P 500. In comparison IRIDEX has a beta of 0.566, suggesting its less volatile than the S&P 500 by 43.407%.
-
Which is a Better Dividend Stock BSGM or IRIX?
BioSig Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioSig Technologies pays -- of its earnings as a dividend. IRIDEX pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSGM or IRIX?
BioSig Technologies quarterly revenues are $13K, which are smaller than IRIDEX quarterly revenues of $11.9M. BioSig Technologies's net income of -$2.8M is lower than IRIDEX's net income of -$1.7M. Notably, BioSig Technologies's price-to-earnings ratio is -- while IRIDEX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioSig Technologies is 172.76x versus 0.36x for IRIDEX. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSGMBioSig Technologies172.76x -- $13K -$2.8M IRIXIRIDEX0.36x -- $11.9M -$1.7M
-
Which has Higher Returns BSGM or MYO?
Myomo has a net margin of -30115.39% compared to BioSig Technologies's net margin of -35.24%. BioSig Technologies's return on equity of -- beat Myomo's return on equity of -38.11%.
Company Gross Margin Earnings Per Share Invested Capital BSGMBioSig Technologies-- -$0.14 $116K MYOMyomo67.23% -$0.08 $21.7M -
What do Analysts Say About BSGM or MYO?
BioSig Technologies has a consensus price target of $10.00, signalling upside risk potential of 110.53%. On the other hand Myomo has an analysts' consensus of $8.70 which suggests that it could grow by 346.15%. Given that Myomo has higher upside potential than BioSig Technologies, analysts believe Myomo is more attractive than BioSig Technologies.
Company Buy Ratings Hold Ratings Sell Ratings BSGMBioSig Technologies1 0 0 MYOMyomo3 0 0 -
Is BSGM or MYO More Risky?
BioSig Technologies has a beta of 1.706, which suggesting that the stock is 70.624% more volatile than S&P 500. In comparison Myomo has a beta of 1.389, suggesting its more volatile than the S&P 500 by 38.863%.
-
Which is a Better Dividend Stock BSGM or MYO?
BioSig Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioSig Technologies pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSGM or MYO?
BioSig Technologies quarterly revenues are $13K, which are smaller than Myomo quarterly revenues of $9.8M. BioSig Technologies's net income of -$2.8M is higher than Myomo's net income of -$3.5M. Notably, BioSig Technologies's price-to-earnings ratio is -- while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioSig Technologies is 172.76x versus 1.97x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSGMBioSig Technologies172.76x -- $13K -$2.8M MYOMyomo1.97x -- $9.8M -$3.5M
-
Which has Higher Returns BSGM or NDRA?
ENDRA Life Sciences has a net margin of -30115.39% compared to BioSig Technologies's net margin of --. BioSig Technologies's return on equity of -- beat ENDRA Life Sciences's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BSGMBioSig Technologies-- -$0.14 $116K NDRAENDRA Life Sciences-- -$1.86 -- -
What do Analysts Say About BSGM or NDRA?
BioSig Technologies has a consensus price target of $10.00, signalling upside risk potential of 110.53%. On the other hand ENDRA Life Sciences has an analysts' consensus of $46.00 which suggests that it could grow by 536.24%. Given that ENDRA Life Sciences has higher upside potential than BioSig Technologies, analysts believe ENDRA Life Sciences is more attractive than BioSig Technologies.
Company Buy Ratings Hold Ratings Sell Ratings BSGMBioSig Technologies1 0 0 NDRAENDRA Life Sciences1 0 0 -
Is BSGM or NDRA More Risky?
BioSig Technologies has a beta of 1.706, which suggesting that the stock is 70.624% more volatile than S&P 500. In comparison ENDRA Life Sciences has a beta of -0.178, suggesting its less volatile than the S&P 500 by 117.84%.
-
Which is a Better Dividend Stock BSGM or NDRA?
BioSig Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ENDRA Life Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioSig Technologies pays -- of its earnings as a dividend. ENDRA Life Sciences pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSGM or NDRA?
BioSig Technologies quarterly revenues are $13K, which are larger than ENDRA Life Sciences quarterly revenues of --. BioSig Technologies's net income of -$2.8M is lower than ENDRA Life Sciences's net income of -$1M. Notably, BioSig Technologies's price-to-earnings ratio is -- while ENDRA Life Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioSig Technologies is 172.76x versus 5.64x for ENDRA Life Sciences. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSGMBioSig Technologies172.76x -- $13K -$2.8M NDRAENDRA Life Sciences5.64x -- -- -$1M
-
Which has Higher Returns BSGM or STXS?
Stereotaxis has a net margin of -30115.39% compared to BioSig Technologies's net margin of -77.93%. BioSig Technologies's return on equity of -- beat Stereotaxis's return on equity of -174.6%.
Company Gross Margin Earnings Per Share Invested Capital BSGMBioSig Technologies-- -$0.14 $116K STXSStereotaxis54.39% -$0.07 $8.2M -
What do Analysts Say About BSGM or STXS?
BioSig Technologies has a consensus price target of $10.00, signalling upside risk potential of 110.53%. On the other hand Stereotaxis has an analysts' consensus of $4.50 which suggests that it could grow by 88.29%. Given that BioSig Technologies has higher upside potential than Stereotaxis, analysts believe BioSig Technologies is more attractive than Stereotaxis.
Company Buy Ratings Hold Ratings Sell Ratings BSGMBioSig Technologies1 0 0 STXSStereotaxis2 0 0 -
Is BSGM or STXS More Risky?
BioSig Technologies has a beta of 1.706, which suggesting that the stock is 70.624% more volatile than S&P 500. In comparison Stereotaxis has a beta of 1.440, suggesting its more volatile than the S&P 500 by 43.964%.
-
Which is a Better Dividend Stock BSGM or STXS?
BioSig Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioSig Technologies pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSGM or STXS?
BioSig Technologies quarterly revenues are $13K, which are smaller than Stereotaxis quarterly revenues of $7.5M. BioSig Technologies's net income of -$2.8M is higher than Stereotaxis's net income of -$5.8M. Notably, BioSig Technologies's price-to-earnings ratio is -- while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioSig Technologies is 172.76x versus 7.49x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSGMBioSig Technologies172.76x -- $13K -$2.8M STXSStereotaxis7.49x -- $7.5M -$5.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
